Results 201 to 210 of about 175,765 (268)

Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis. [PDF]

Drug Des Devel Ther
Shi L, Li S, Yao X, Zhang Z, Dong Q, Zhang H, Wang X, Bai J, Han H, Fu X, Zheng K, Liang L.   +11 more
europepmc   +1 more source

Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

Schiffer L, Anthony AV, Wittemans LBL, Taylor AE, Oestlund I, Miranda AM, Melson E, McDonnell T, Kempegowda P, Smith P, Clark TJ, Wabitsch M, O’Reilly MW, Peters M, Wagenfeld A, Ingwersen J, Snoep JL, Scott WR, Hilpert J, Storbeck K, Arlt W.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Androgens and androgen receptors in breast cancer

The Journal of Steroid Biochemistry and Molecular Biology, 2007
Aromatase (CYP19) converts adrenal and ovarian androgens into estrogens, which supports the growth of estrogen-dependent breast cancers. Anti-aromatase agents are displacing antiestrogens as the first-line treatment for estrogen receptor positive breast cancers.
B, Nicolás Díaz-Chico, F, Germán Rodríguez, Ana, González, Raquel, Ramírez, Cristina, Bilbao, A, Cabrera de León, A, Aguirre Jaime, Ricardo, Chirino, Domingo, Navarro, Juan C, Díaz-Chico   +9 more
openaire   +2 more sources

Androgens, Antiandrogens and Androgen Receptor Abnormalities

European Urology, 1996
Information on the molecular structure of the human androgen receptor has increased insight into the molecular mechanism of action of androgens and antiandrogens. It has also facilitated the study of molecular defects in the androgen receptor gene associated with prostate cancer.
C W, Kuil, A O, Brinkmann
openaire   +2 more sources